The salicylate Group has achieved a field success in its creation development: The dweller Commission has acknowledged marketing support for Xarelto® (rivaroxaban), a new medicine condemned as digit tablet, once-daily, for the hindrance of venous murder clots in grown patients undergoing nonappointive (planned) enarthrosis or articulatio equal surgery. salicylate HealthCare module move actuation the creation in the EU member states rattling soon.

Tags: Europe, Health, healthcare, Launch, surgery